Investigation of the Capacity of Low Glass Transition Temperature Excipients to Minimize Amorphization of Sulfadimidine on Comilling

被引:27
作者
Curtin, Vincent
Amharar, Youness
Hu, Yun [2 ]
Erxleben, Andrea [2 ]
McArdle, Patrick [2 ]
Caron, Vincent
Tajber, Lidia
Corrigan, Owen I.
Healy, Anne Marie [1 ]
机构
[1] Univ Dublin Trinity Coll, Sch Pharm & Pharmaceut Sci, Panoz Inst, Dublin 2, Ireland
[2] Natl Univ Ireland, Sch Chem, Galway, Ireland
基金
爱尔兰科学基金会;
关键词
glass transition; amorphous; comilling; solubility; excipient; thermal methods; vapor sorption; X-ray diffraction; DYNAMIC VAPOR SORPTION; AMORPHOUS PHARMACEUTICAL SOLIDS; NEAR-INFRARED SPECTROSCOPY; SOLUBILITY PARAMETERS; STATE; CRYSTALLINE; INDOMETHACIN; STABILITY; POLYVINYLPYRROLIDONE; QUANTIFICATION;
D O I
10.1021/mp300529a
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The coprocessing of active pharmaceutical ingredient (API) with an excipient which has a high glass transition temperature (T-g) is a recognized strategy to stabilize the amorphous form of a drug. This work investigates whether coprocessing a model API, sulfadimidine (SDM) with a series of low T-g excipients, prevents or reduces amorphization of the crystalline drug. It was hypothesized that these excipients could exert a T-g lowering effect, resulting in composite T-g values lower than that of the API alone and promote crystallization of the drug. Milled SDM and comilled SDM with glutaric acid (GA), adipic acid (AA), succinic acid (SA), and malic acid (MA) were characterized with respect to their thermal, X-ray diffraction, spectroscopic, and vapor sorption properties. SDM was predominantly amorphous when milled alone, with an amorphous content of 82%. No amorphous content was detected by dynamic vapor sorption (DVS) on comilling SDM with 50% w/w GA, and amorphous content of the API was reduced by almost 30%, relative to the API milled alone, on comilling with 50% w/w AA. In contrast, amorphization of SDM was promoted on comilling with 50% w/w SA and MA, as indicated by near-infrared (NIR) spectroscopy. Results indicated that the API was completely amorphized in the SDM:MA comilled composite. The saturated solubility of GA and AA in the amorphous API was estimated by thermal methods. It was observed that the T-g of the comelt quenched composites reached a minimum and leveled out at this solubility concentration. Maximum crystallinity of API on comilling was reached at excipient concentrations comparable to the saturated concentration solubility of excipient in the API. Moreover, the closer the Hildebrand solubility parameter of the excipient to the API, the greater the inhibition of API amorphization on comilling. The results reported here indicate that an excipient with a low T-g coupled with high solubility in the API can prevent or reduce the generation of an amorphous phase on comilling.
引用
收藏
页码:386 / 396
页数:11
相关论文
共 51 条
[1]   Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen-cimetidine mixtures prepared by mechanical activation [J].
Alleso, Morten ;
Chieng, Norman ;
Rehder, Soenke ;
Rantanen, Jukka ;
Rades, Thomas ;
Aaltonen, Jaakko .
JOURNAL OF CONTROLLED RELEASE, 2009, 136 (01) :45-53
[2]  
Anderton C.L., 2003, Pharmaceutical Analysis. Vibrational spectroscopy in pharmaceutical analysis, P203
[3]  
[Anonymous], 2001, INFRARED RAMAN CHARA, DOI DOI 10.1002/JRS.1238
[4]   Influence of Excipients in Comilling on Mitigating Milling-Induced Amorphization or Structural Disorder of Crystalline Pharmaceutical Actives [J].
Balani, Prashant N. ;
Ng, Wai Kiong ;
Tan, Reginald B. H. ;
Chan, Sui Yung .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (05) :2462-2474
[5]   Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns [J].
Bates, Simon ;
Zografi, George ;
Engers, David ;
Morris, Kenneth ;
Crowley, Kieran ;
Newman, Ann .
PHARMACEUTICAL RESEARCH, 2006, 23 (10) :2333-2349
[6]   Influence of mechanical activation on the physical stability of salbutamol sulphate [J].
Brodka-Pfeiffer, K ;
Langguth, P ;
Grass, P ;
Häusler, H .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (03) :393-400
[7]   Studies on the crystallinity of a pharmaceutical development drug substance [J].
Byard, SJ ;
Jackson, SL ;
Smail, A ;
Bauer, M ;
Apperley, DC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (06) :1321-1335
[8]   A Comparison of Spray Drying and Milling in the Production of Amorphous Dispersions of Sulfathiazole/Polyvinylpyrrolidone and Sulfadimidine/Polyvinylpyrrolidone [J].
Caron, Vincent ;
Tajber, Lidia ;
Corrigan, Owen I. ;
Healy, Anne Marie .
MOLECULAR PHARMACEUTICS, 2011, 8 (02) :532-542
[9]   The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state [J].
Crowley, KJ ;
Zografi, G .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1417-1422
[10]   Transformation of pharmaceutical compounds upon milling and comilling:: The role of Tg [J].
Descamps, M. ;
Willart, J. F. ;
Dudognon, E. ;
Caron, V. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (05) :1398-1407